Chemotherapy with Doxorubicin, Etoposide and Cyclophosphamide (DEC) in Ovarian Cancer Persistent after Platinum-based Treatment

By Zanetta G.   Monico S.L.   Gabriele A.   Miceli D.   Mangioni C.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 178-179

Elsevier

Access to resources Recommend Favorite

Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)

By Chaudhry Parvesh   Srinivasan Radhika   Patel Firuza  

Cancer Investigation, Vol. 27, Iss. 8, 2009-10 ,pp. : 877-884

Informa Healthcare

Access to resources Recommend Favorite

Long-term Prognosis Following Macroscopic Complete Response at Second-look Laparotomy in Advanced Ovarian Cancer Patients Treated with Platinum-based Chemotherapy

By Chiara S.   Lionetto R.   Campora E.   Oliva C.   Merlini L.   Bruzzi P.   Rosso R.   Conte P.F.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 296-301

Elsevier

Access to resources Recommend Favorite

Paclitaxel-Anthracycline Combination Chemotherapy in Relapsing Advanced Ovarian Cancer after Platinum-Based Chemotherapy: A Pilot Study

By Kurtz J.E.   Deplanque G.   Duclos B.   Eichler F.   Giron C.   Limacher J.M.   Herbrecht R.   Maloisel F.   Oberling F.   Bergerat J.P.   Dufour P.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 414-417

Elsevier

Access to resources Recommend Favorite

Platinum-Based Chemotherapy for Advanced-Stage Serous Ovarian Carcinoma of Low Malignant Potential

By Barakat R.R.   Benjamin I.   Lewis Jr. J.L.   Saigo P.E.   Curtin J.P.   Hoskins W.J.  

Gynecologic Oncology, Vol. 59, Iss. 3, 1995-12 ,pp. : 390-393

Academic Press

Access to resources Recommend Favorite